-
1
-
-
33745863033
-
Islet cell failure in type 2 diabetes
-
Prentki M, Nolan CJ. Islet cell failure in type 2 diabetes. J Clin Invest. 2006;116(7):1802-1812.
-
(2006)
J Clin Invest
, vol.116
, Issue.7
, pp. 1802-1812
-
-
Prentki, M.1
Nolan, C.J.2
-
2
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-853.
-
(1998)
Lancet
, vol.352
, Issue.9131
, pp. 837-853
-
-
-
3
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
UK Prospective Diabetes Study (UKPDS) Group
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):854-865.
-
(1998)
Lancet
, vol.352
, Issue.9131
, pp. 854-865
-
-
-
4
-
-
84868652782
-
Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: A cohort study
-
Roumie CL, Hung AM, Greevy RA, et al. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012;157(9):601-610.
-
(2012)
Ann Intern Med
, vol.157
, Issue.9
, pp. 601-610
-
-
Roumie, C.L.1
Hung, A.M.2
Greevy, R.A.3
-
5
-
-
84873656406
-
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes
-
Currie CJ, PooleCD,EvansM,Peters JR,MorganCL. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. 2013;98(2):668-677.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, Issue.2
, pp. 668-677
-
-
Currie, C.J.1
Poole, C.D.2
Evans, M.3
Peters, J.R.4
Morgan, C.L.5
-
6
-
-
0038279359
-
Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
-
Johnson JA, Majumdar SR, Simpson SH, Toth EL. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care. 2002; 25(12):2244-2248.
-
(2002)
Diabetes Care
, vol.25
, Issue.12
, pp. 2244-2248
-
-
Johnson, J.A.1
Majumdar, S.R.2
Simpson, S.H.3
Toth, E.L.4
-
7
-
-
84912100243
-
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: A retrospective, observational study
-
Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ. Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab. 2014;16(10):957-962.
-
(2014)
Diabetes Obes Metab
, vol.16
, Issue.10
, pp. 957-962
-
-
Morgan, C.L.1
Mukherjee, J.2
Jenkins-Jones, S.3
Holden, S.E.4
Currie, C.J.5
-
8
-
-
84860117993
-
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database
-
Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009;339:b4731.
-
(2009)
BMJ
, vol.339
, pp. b4731
-
-
Tzoulaki, I.1
Molokhia, M.2
Curcin, V.3
-
9
-
-
84914165449
-
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
-
Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014;16(11):1165-1173.
-
(2014)
Diabetes Obes Metab
, vol.16
, Issue.11
, pp. 1165-1173
-
-
Bannister, C.A.1
Holden, S.E.2
Jenkins-Jones, S.3
-
10
-
-
84871237743
-
-
World Health Organization. Oslo:WHOCollaborating Centre for Drug Statistics Methodology
-
World Health Organization. Guidelines for ATC Classification and DDDAssignment. Oslo:WHOCollaborating Centre for Drug Statistics Methodology; 2015.
-
(2015)
Guidelines for ATC Classification and DDDAssignment
-
-
-
11
-
-
84959424020
-
-
Lash. Modern Epidemiology. Lippincott Williams, Wilkins; Philadelphia, PA:
-
Kenneth J. Rothman SG, Timothy L. Lash. Modern Epidemiology. Lippincott Williams, Wilkins; Philadelphia, PA: 2008.
-
(2008)
Rothman SG, Timothy L
-
-
Kenneth, J.1
-
12
-
-
44049108508
-
The secret of immortal time bias in epidemiologic studies
-
Shariff SZ, Cuerden MS, Jain AK, Garg AX. The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol. 2008;19(5): 841-843.
-
(2008)
J Am Soc Nephrol
, vol.19
, Issue.5
, pp. 841-843
-
-
Shariff, S.Z.1
Cuerden, M.S.2
Jain, A.K.3
Garg, A.X.4
-
13
-
-
85088938629
-
-
The Statistical Analysis of Failure Time Data. John Wiley, Sons; Hoboken, NJ:
-
John D. Kalbfleisch RLP. The Statistical Analysis of Failure Time Data. John Wiley, Sons; Hoboken, NJ: 2011.
-
(2011)
Kalbfleisch RLP
-
-
John, D.1
-
14
-
-
70449647008
-
Proportional hazards tests and diagnostics based on weighted residuals
-
Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3): 515-526.
-
(1994)
Biometrika
, vol.81
, Issue.3
, pp. 515-526
-
-
Grambsch, P.M.1
Therneau, T.M.2
-
15
-
-
79961135005
-
-
R Development Core Team.. Vienna: the R Foundation for Statistical Computing
-
R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: the R Foundation for Statistical Computing. 2011. http://www. R-project. org/.
-
(2011)
R: A Language and Environment for Statistical Computing
-
-
-
17
-
-
77749296886
-
-
Wickham, Hadley.. 2010 edition. Springer-Verlag; New York, NY 1st Ed. Corrected 3rd Printing
-
Wickham, Hadley. ggplot2: Elegant Graphics for Data Analysis. 1st ed. Corrected 3rd printing. 2010 edition. Springer-Verlag; New York, NY: 2009.
-
(2009)
Ggplot2: Elegant Graphics for Data Analysis
-
-
-
18
-
-
77950874655
-
Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: A nested case-control study
-
Azoulay L, Schneider-Lindner V, Dell'aniello S, Schiffrin A, Suissa S. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010;19(4):335-342.
-
(2010)
Pharmacoepidemiol Drug Saf
, vol.19
, Issue.4
, pp. 335-342
-
-
Azoulay, L.1
Schneider-Lindner, V.2
Dell'Aniello, S.3
Schiffrin, A.4
Suissa, S.5
-
19
-
-
84895816458
-
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
-
Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013;11: CD008143.
-
(2013)
Cochrane Database Syst Rev
, vol.11
, pp. CD008143
-
-
Hemmingsen, B.1
Lund, S.S.2
Gluud, C.3
-
20
-
-
34447117471
-
Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration
-
Kahler KH, Rajan M, Rhoads GG, et al. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration. Diabetes Care. 2007; 30(7):1689-1693.
-
(2007)
Diabetes Care
, vol.30
, Issue.7
, pp. 1689-1693
-
-
Kahler, K.H.1
Rajan, M.2
Rhoads, G.G.3
-
21
-
-
84864270406
-
Basal insulin and cardiovascular and other outcomes in dysglycemia
-
ORIGIN Trial Investigators
-
ORIGIN Trial Investigators, Gerstein HC, Bosch J, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. NEngl J Med. 2012;367(4):319-328.
-
(2012)
NEngl J Med
, vol.367
, Issue.4
, pp. 319-328
-
-
Gerstein, H.C.1
Bosch, J.2
-
22
-
-
79958197888
-
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study
-
Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. 2011; 32(15):1900-1908.
-
(2011)
Eur Heart J
, vol.32
, Issue.15
, pp. 1900-1908
-
-
Schramm, T.K.1
Gislason, G.H.2
Vaag, A.3
-
23
-
-
84881567755
-
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy
-
Wheeler S, Moore K, Forsberg CW, et al. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy. Diabetologia. 2013;56(9):1934-1943.
-
(2013)
Diabetologia
, vol.56
, Issue.9
, pp. 1934-1943
-
-
Wheeler, S.1
Moore, K.2
Forsberg, C.W.3
-
24
-
-
73349095732
-
Insulin use and increased risk of mortality in type 2 diabetes: A cohort study
-
Gamble JM, Simpson SH, Eurich DT, Majumdar SR, Johnson JA. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab. 2010;12(1):47-53.
-
(2010)
Diabetes Obes Metab
, vol.12
, Issue.1
, pp. 47-53
-
-
Gamble, J.M.1
Simpson, S.H.2
Eurich, D.T.3
Majumdar, S.R.4
Johnson, J.A.5
-
25
-
-
79955466395
-
Lipid control in patients with diabetes mellitus
-
Betteridge DJ. Lipid control in patients with diabetes mellitus. Nat Rev Cardiol. 2011;8(5):278-290.
-
(2011)
Nat Rev Cardiol
, vol.8
, Issue.5
, pp. 278-290
-
-
Betteridge, D.J.1
-
26
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
-
ColhounHM,Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696.
-
(2004)
Lancet
, vol.364
, Issue.9435
, pp. 685-696
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
-
27
-
-
85144841000
-
Using multivariate matched sampling and regression adjustment to control bias in observational studies
-
Rubin DB. Using multivariate matched sampling and regression adjustment to control bias in observational studies. J Am Stat Assoc. 1979;74(366):318-328.
-
(1979)
J Am Stat Assoc
, vol.74
, Issue.366
, pp. 318-328
-
-
Rubin, D.B.1
-
28
-
-
0019575722
-
Matching in epidemiologic studies: Validity and efficiency considerations
-
Kupper LL, Karon JM, Kleinbaum DG, Morgenstern H, Lewis DK. Matching in epidemiologic studies: validity and efficiency considerations. Biometrics. 1981;37(2):271-291.
-
(1981)
Biometrics
, vol.37
, Issue.2
, pp. 271-291
-
-
Kupper, L.L.1
Karon, J.M.2
Kleinbaum, D.G.3
Morgenstern, H.4
Lewis, D.K.5
-
29
-
-
0030731208
-
ConfounDing and indication for treatment in evaluation of drug treatment for hypertension
-
Grobbee DE, Hoes AW. ConfounDing and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997; 315(7116):1151-1154.
-
(1997)
BMJ
, vol.315
, Issue.7116
, pp. 1151-1154
-
-
Grobbee, D.E.1
Hoes, A.W.2
-
30
-
-
0033054397
-
Assessment and control for confounDing by indication in observational studies
-
Psaty BM, Koepsell TD, Lin D, l. Assessment and control for confounDing by indication in observational studies. J Am Geriatr Soc. 1999;47(6):749-754.
-
(1999)
J Am Geriatr Soc
, vol.47
, Issue.6
, pp. 749-754
-
-
Psaty, B.M.1
Koepsell, T.D.2
Lin, D.L.3
-
31
-
-
70649113093
-
A most stubborn bias: No adjustment method fully resolves confounDing by indication in observational studies
-
Bosco JL, Silliman RA, Thwin SS, et al. A most stubborn bias: no adjustment method fully resolves confounDing by indication in observational studies. J Clin Epidemiol. 2010;63(1):64-74.
-
(2010)
J Clin Epidemiol
, vol.63
, Issue.1
, pp. 64-74
-
-
Bosco, J.L.1
Silliman, R.A.2
Thwin, S.S.3
-
32
-
-
19144368778
-
The use of the propensity score for estimating treatment effects: Administrative versus clinical data
-
Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med. 2005;24(10):1563-1578.
-
(2005)
Stat Med
, vol.24
, Issue.10
, pp. 1563-1578
-
-
Austin, P.C.1
Mamdani, M.M.2
Stukel, T.A.3
Anderson, G.M.4
Tu, J.V.5
|